Advanced Asset Management Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $581K | Sell |
484
-1
| -0.2% | -$1.02K | 0.15% | 46 |
|
|
2026
Q1 | $446K | Hold |
485
| – | – | 0.12% | 48 |
|
|
2025
Q4 | $521K | Sell |
485
-1
| -0.2% | -$956 | 0.14% | 48 |
|
|
2025
Q3 | $371K | Buy |
486
+2
| +0.4% | +$1.49K | 0.1% | 50 |
|
|
2025
Q2 | $377K | Hold |
484
| – | – | 0.1% | 50 |
|
|
2025
Q1 | $400K | Sell |
484
-1
| -0.2% | -$832 | 0.11% | 51 |
|
|
2024
Q4 | $374K | Buy |
485
+127
| +35% | +$105K | 0.1% | 56 |
|
|
2024
Q3 | $324K | Hold |
358
| – | – | 0.09% | 59 |
|
|
2024
Q2 | $324K | Sell |
358
-43
| -11% | -$34.4K | 0.09% | 60 |
|
|
2024
Q1 | $312K | Hold |
401
| – | – | 0.08% | 62 |
|
|
2023
Q4 | $234K | Sell |
401
-294
| -42% | -$172K | 0.06% | 69 |
|
|
2023
Q3 | $374K | Sell |
695
-25
| -3% | -$12.9K | 0.09% | 61 |
|
|
2023
Q2 | $338K | Sell |
720
-3
| -0.4% | -$1.26K | 0.08% | 63 |
|
|
2023
Q1 | $248K | Hold |
723
| – | – | 0.06% | 69 |
|
|
2022
Q4 | $265K | Hold |
723
| – | – | 0.07% | 67 |
|
|
2022
Q3 | $234K | Buy |
723
+30
| +4% | +$9.51K | 0.06% | 67 |
|
|
2022
Q2 | $225K | Buy |
+693
| New | +$208K | 0.06% | 69 |
|
|
2022
Q1 | – | Sell |
-910
| Closed | -$251K | – | 92 |
|
|
2021
Q4 | $251K | Hold |
910
| – | – | 0.05% | 68 |
|
|
2021
Q3 | $210K | Sell |
910
-440
| -33% | -$109K | 0.05% | 75 |
|
|
2021
Q2 | $310K | Sell |
1,350
-139
| -9% | -$27.9K | 0.07% | 66 |
|
|
2021
Q1 | $278K | Sell |
1,489
-75
| -5% | -$14.7K | 0.06% | 74 |
|
|
2020
Q4 | $264K | Buy |
1,564
+1
| +0.1% | +$149 | 0.06% | 73 |
|
|
2020
Q3 | $231K | Buy |
1,563
+1
| +0.1% | +$155 | 0.06% | 74 |
|
|
2020
Q2 | $257K | Sell |
1,562
-500
| -24% | -$76.8K | 0.08% | 69 |
|
|
2020
Q1 | $286K | Sell |
2,062
-59
| -3% | -$8.11K | 0.1% | 79 |
|
|
2019
Q4 | $279K | Sell |
2,121
-60
| -3% | -$6.96K | 0.08% | 81 |
|
|
2019
Q3 | $244K | Buy |
2,181
+1
| +0% | +$111 | 0.08% | 88 |
|
|
2019
Q2 | $242K | Sell |
2,180
-401
| -16% | -$47.2K | 0.08% | 86 |
|
|
2019
Q1 | $335K | Sell |
2,581
-685
| -21% | -$83.3K | 0.12% | 93 |
|
|
2018
Q4 | $378K | Buy |
+3,266
| New | +$365K | 0.12% | 106 |
|
|
2018
Q3 | – | Sell |
-3,265
| Closed | -$279K | – | 109 |
|
|
2018
Q2 | $279K | Buy |
3,265
+1
| +0% | +$82 | 0.09% | 118 |
|
|
2018
Q1 | $253K | Buy |
3,264
+1
| +0% | +$81 | 0.08% | 117 |
|
|
2017
Q4 | $276K | Buy |
+3,263
| New | +$278K | 0.09% | 118 |
|
Other funds holding LLY
SC
ONB
GIM
CRM
VNIM
CNB
Advanced Asset Management Advisors's LLY Position: Q2 2026 in Review
Advanced Asset Management Advisors reduced its Eli Lilly (LLY) stake by 0.21% in Q2 2026, selling an estimated $1.02K and leaving 484 shares worth $581K. The position accounts for 0.15% of the portfolio, ranked #46.
Advanced Asset Management Advisors first reported a position in LLY in Q4 2017 and has held it in 33 quarters since. 841 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Advanced Asset Management Advisors held 484 shares of Eli Lilly worth $581K as of Q2 2026.
- Advanced Asset Management Advisors sold 1 Eli Lilly share in Q2 2026, an estimated $1.02K.
- Eli Lilly made up 0.15% of Advanced Asset Management Advisors's portfolio in Q2 2026, its #46 holding.
- Advanced Asset Management Advisors first reported a position in Eli Lilly in Q4 2017 and has held it in 33 quarters since.
- 841 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Advanced Asset Management Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.